Magazine highlights

View more from the latest edition
Thumbnail image for SMART PEOPLE INSIGHT: Dr Jan Westerink

SMART PEOPLE INSIGHT: Dr Jan Westerink

A new, pooled analysis of data from Novo Nordisk’s Phase III trials SUSTAIN 6 and PIONEER 6 shows that semaglutide may help patients with type 2 diabetes live longer without a cardiovascular event. PharmaTimes talks to lead study investigator Dr Jan Westerink about the importance of these findings

Thumbnail image for R&D trends

R&D trends

Accelerating innovation and its impact on patients and sites

Thumbnail image for Movers and shakers

Movers and shakers

As mega deals slow, private capital becomes the driving force behind 2020 M&A

Thumbnail image for Responding to the crisis

Responding to the crisis

Oli Hudson explores the changes that have occurred in the NHS this year as the Long Term Plan has been rolled out at speed in response to the COVID crisis

Thumbnail image for A critical juncture

A critical juncture

Leslie Galloway looks back over 2020, outlining the challenges faced by the life sciences sector and the potential opportunities that lie ahead

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download